Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA - Wikidata - wikimedia - TriplyDB

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

http://www.wikidata.org/entity/Q24672943

about

Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma Current Treatment Approaches to HCC with a Special Consideration to Transplantation Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation Liver transplantation for hepatic tumors: a systematic review [18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma.Living donor liver transplantation for hepatocellular carcinoma achieves better outcomes Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.Increasing survival of hepatocellular carcinoma patients in Scotland: a review of national cancer registry data.Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation.Value of radiofrequency ablation in the treatment of hepatocellular carcinoma Hepatocellular carcinoma: early-stage management challenges Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria.A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma after liver transplantation.Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies.Salvage liver transplantation for recurrent hepatocellular carcinoma within UCSF criteria after liver resection The impact of liver transplantation after surgical treatment of hepatocellular carcinoma Surgical treatment for hepatocellular carcinoma Major challenges limiting liver transplantation in the United States.Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC.Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome.Hong Kong consensus recommendations on the management of hepatocellular carcinoma.Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report.NCCN clinical practice guidelines in oncology: hepatobiliary cancers Management of Hepatocellular Carcinoma: Current Status and Future Directions.Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis Management and prevention of post-transplant malignancies in kidney transplant recipients Hepatocellular carcinoma: natural history, current management, and emerging tools.Liver transplantation in adults: Choosing the appropriate timing A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma Liver Transplantation for Hepatocellular Carcinoma: A Single Center Resume Overlooking Four Decades of Experience.Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria.Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5.Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.National Cancer Centre Singapore Consensus Guidelines for Hepatocellular Carcinoma.

P2860

Q26740332-637FD3AF-68E9-4435-BFFC-B3DF7907BD55 Q26740375-EBE25F79-A3E6-473D-9630-58C9E896B348 Q26750463-3E20291A-B1F2-4877-863B-30E7500F4B05 Q26771246-CB0987CE-5BB8-4786-87BE-7806F5CB988A Q27005375-6AD5B455-6527-4C15-BCDC-0FE82352402F Q27021650-35DAE6EF-018F-47FA-A8CE-F5C751B8E275 Q27691331-AE858FFE-4FE0-44B6-A6A0-1B3CA37F8032 Q28073611-0593BB21-9ACF-4637-9A02-C7ACBD39679E Q30276330-D6CD534B-FE42-4986-9E32-AADD2C4A8D10 Q30596607-F9D5B68D-BE45-4265-8CA8-C10C604FF7E1 Q33408291-F22D7A13-F47E-4380-8325-64BD6FC3E86F Q33661046-297E2ABF-BF48-4A4A-AF52-959578F6A031 Q33881131-35514DFC-4777-43CE-ABE4-267FEC170C42 Q33913779-185BA218-28B3-4B20-AD84-3CE3E0302774 Q34038193-51A2AEEE-E970-4FE8-82DE-6E9EA520CA16 Q34080277-FE1F568C-3773-45EE-B713-09C9D3BA1B44 Q34080984-5E05AF5A-A61D-43DC-8936-7AB2E08A13CC Q34409128-55843628-A4B2-4403-BE76-B109ABA4F95B Q34473754-3D3F0F5F-CC35-49B0-A12E-FDED3E62AE42 Q34868567-7641EE64-1A6A-445E-9731-9B57F82C2C19 Q35166162-5A584BA4-AF7E-4AEE-83CE-5A20F1FBA4B0 Q35194675-8D6C50F4-F138-42CD-8FB5-7493C7AFCF1A Q35207762-D287D6D3-1917-4D7A-8C64-4CD6A0D8917D Q35626757-ACB0D6E1-A441-4EBA-98BE-D457FF8A1072 Q35631295-D2A784AE-EAC3-492C-8C53-37C63BD0C4DB Q35634422-F983657A-2E4A-4DD3-857F-7EE234444F5A Q35703937-4FBCF61A-3859-4014-87E3-3FA53B4F65B2 Q35771842-6DA00C65-D436-49ED-94FE-5CAEE2524970 Q36063276-88B64642-6AC0-4E9D-BFCE-2791A0B993E2 Q36088854-3F472FCD-9779-47AB-BA21-5CE42EC478BA Q36171275-973B4035-D3A3-4D89-8252-360EA2BBC6C7 Q36220176-877B0D45-29DE-4D73-9C22-6EC18E17C030 Q36302710-88607353-0B9E-4BC1-9B8C-01BD19EFCF82 Q36532133-86F88659-974C-4633-A9B8-29B4B8C20E93 Q36643551-10C9AF6A-F315-46A6-A22B-A65BBDB9DE25 Q36702287-1A8169C9-B6E7-4693-81A8-0C0A769597D2 Q36728731-D4881C05-8DBA-45EA-9E33-AAFD6C93DEC7 Q36733226-54FE5B55-ACDC-4652-A149-AD4A9602CB3F Q36962089-046FFE84-6030-4FAF-847A-EA7D8EB1F46C Q37000692-5A93CC2C-5651-413F-B71F-44E2F3FFDAA5

P2860

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

http://www.wikidata.org/entity/Q24672943

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Liver transplantation criteria ...... ence with 467 patients at UCLA

@ast

Liver transplantation criteria ...... ence with 467 patients at UCLA

@en

Liver transplantation criteria ...... ence with 467 patients at UCLA

@nl

type

label

Liver transplantation criteria ...... ence with 467 patients at UCLA

@ast

Liver transplantation criteria ...... ence with 467 patients at UCLA

@en

Liver transplantation criteria ...... ence with 467 patients at UCLA

@nl

prefLabel

Liver transplantation criteria ...... ence with 467 patients at UCLA

@ast

Liver transplantation criteria ...... ence with 467 patients at UCLA

@en

Liver transplantation criteria ...... ence with 467 patients at UCLA

@nl

P1433

Q24672943-75E0E65D-8CF1-45F1-991C-DE07A7CBB141

P1476

Q24672943-F4019232-130D-498E-A11A-5B56192B850A

P2093

Q24672943-03F5AA42-79B0-4350-9198-EF76407F7264

Q24672943-055CFEC0-1582-4AC9-862B-F8B0EEDC017B

Q24672943-0C2162EB-2170-40DB-BEF7-20FDB8829A0E

Q24672943-35242028-171D-4E33-9FB8-4C637FA2FB08

Q24672943-4A4C562C-A731-47FE-A14C-7E4E2208C0D6

Q24672943-4E79F21B-8810-4C7F-9CB0-EDBB1C488249

Q24672943-6B9BBACA-5CF5-463E-8DCA-372663BFAFEA

Q24672943-74C914F1-3261-4A7C-B291-130DAC7F8C29

Q24672943-8DF46C3A-36E2-4DE4-A0CB-1A66A93B8525

Q24672943-A6D98B1E-059B-4CC1-BF07-A7C7153D0026

P2860

Q24672943-00039A5C-DFB8-47CE-82A1-29B19BE771CA

Q24672943-03C219FE-BE4A-41C8-BA75-0C83845E03DD

Q24672943-06970513-8325-4FCF-A4AD-DC6E593A48BA

Q24672943-145D48AD-9763-4B3F-8020-119A58DE76C1

Q24672943-1A3E91FA-0DF3-4C2F-AEC6-9966BBAD0B9E

Q24672943-2EB03941-B4F9-4DE9-9CF6-1D4B15359CDE

Q24672943-2F9A9A0F-4A14-4C62-BAAB-CFA1AA74CB3D

Q24672943-372E605B-DD8F-45BD-993F-5078445D07B1

Q24672943-3BAEC469-1B40-4AC0-BC0E-F594D90309B5

Q24672943-3C922026-77A2-4017-BB59-CAD42C36F87D

P304

Q24672943-DA66CD3F-56A3-4E82-A713-53197CEB09A9

P31

Q24672943-D3901F9C-0693-42BD-9F46-F11BE057E327

P3181

Q24672943-9FF2774C-124C-40F7-A7EC-69A989EBC6A5

P356

Q24672943-818D7823-1FF2-4B7C-A5FA-AFA772A547CB

P407

Q24672943-EAD211DB-8506-4A22-9135-057F02D790B0

P433

Q24672943-E4CAF545-AB6B-43DA-AF60-C6FBC0CA4A61

P478

Q24672943-3F3C1F42-18AA-430C-95D4-E1D18D897F84

P50

Q24672943-3DF1D9D7-BCBE-4F9E-9F01-6C20AE84ACF6

P577

Q24672943-6C257A92-C564-4D65-954B-4E2A6EEB5AD7

P698

Q24672943-4C06738B-9E1F-4802-95C0-B2A55ABC817A

P921

Q24672943-F5891F71-0E34-4AE0-9F4E-51DC9D17980F

P932

Q24672943-55D6D871-3D26-433D-B176-27EF82F6A3F4

P3181

P356

SLA.0B013E318148C704

P1433

Annals of Surgery

P1476

Liver transplantation criteria ...... ence with 467 patients at UCLA

@en

P2093

Andrew Vardanian

http://www.w3.org/2001/XMLSchema#string

Charles Lassman

http://www.w3.org/2001/XMLSchema#string

David S K Lu

http://www.w3.org/2001/XMLSchema#string

Douglas G Farmer

http://www.w3.org/2001/XMLSchema#string

Elizabeth Benjamin

http://www.w3.org/2001/XMLSchema#string

Gerald Lipshutz

http://www.w3.org/2001/XMLSchema#string

Hasan Yersiz

http://www.w3.org/2001/XMLSchema#string

John P Duffy

http://www.w3.org/2001/XMLSchema#string

Jonathan R Hiatt

http://www.w3.org/2001/XMLSchema#string

Melissa Watson

http://www.w3.org/2001/XMLSchema#string

P2860

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma

A model to predict survival in patients with end-stage liver disease

Hepatocellular carcinoma

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era.

The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma.

Hepatocellular carcinoma: recent trends in the United States.

Should we biopsy each liver mass suspicious for hepatocellular carcinoma before liver transplantation?--yes.

Chronic viral hepatitis and hepatocellular carcinoma.

P304

502-9; discussion 509-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

668561

http://www.w3.org/2001/XMLSchema#string

P356

10.1097/SLA.0B013E318148C704

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

246

http://www.w3.org/2001/XMLSchema#string

P50

Ronald W Busuttil

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17717454

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation

P932

1959350

http://www.w3.org/2001/XMLSchema#string